Potential roles of nucleotide-binding oligomerization domain 2 in the pathogenesis of systemic lupus erythematosus

被引:6
|
作者
Li, Jing [1 ]
Wu, Song [1 ]
Wang, Ming-Rui [1 ]
Wang, Ting-Ting [1 ]
Li, Bai-kun [1 ]
Zhu, Ji-Min [1 ]
机构
[1] Anhui Univ Chinese Med, Sch Integrated Tradit & Western Med, Dept Publ Hlth & Gen Med, Hefei 230038, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
NOD2; Systemic lupus erythematosus; Therapeutic target; Immune; TOLL-LIKE RECEPTORS; INNATE IMMUNE-RESPONSES; CROHNS-DISEASE; DENDRITIC CELLS; EPITHELIAL-CELLS; PEPTIDOGLYCAN RECOGNITION; INFLAMMATORY DISEASE; MULTIPLEX FAMILIES; CHROMOSOME; 16Q12; LRR PROTEINS;
D O I
10.1007/s00296-014-2975-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nucleotide-binding oligomerization domain 2 (NOD2) is one of the most prominent member of the NOD-like receptors protein family that functions as intracellular pattern recognition receptors. Numerous studies have suggested the importance of NOD2 in defensing against microbial infections, regulation of the inflammatory process. It is shown that NOD2 contributes to the pathogenesis of various autoimmune and chronic inflammatory diseases, such as Crohn's disease, rheumatoid arthritis. The aim of this study is to summarize our current understandings of NOD2 function and the role of NOD2 in systemic lupus erythematosus (SLE). The following databases were searched: Pubmed, EMBASE and Web of Science for English-language sources, using the terms "lupus," "systemic lupus erythematosus," ''SLE," "immunity," "inflammatory" and "NOD2." Emerging data evidences that NOD2 has important biological effects in autoimmunity and inflammatory and might take part in the pathogenesis of SLE. Studies exploring the relationship between NOD2 and SLE are very limited. Whether NOD2 could be a potentially valuable therapeutic target for treatment for SLE, more understanding of the mechanism of NOD2 is needed in the future in SLE.
引用
收藏
页码:1339 / 1344
页数:6
相关论文
共 50 条
  • [1] Potential roles of nucleotide-binding oligomerization domain 2 in the pathogenesis of systemic lupus erythematosus
    Jing Li
    Song Wu
    Ming-Rui Wang
    Ting-Ting Wang
    Bai-kun Li
    Ji-Min Zhu
    [J]. Rheumatology International, 2014, 34 : 1339 - 1344
  • [2] A Novel Biomarker: Nucleotide-Binding Oligomerization Domain 27 in Systemic Lupus Erythematosus
    Cutinha, Annika
    Yu, Yangsheng
    Su, Kaihong
    O'Dell, James R.
    Klassen, Lynell W.
    Cannella, Amy C.
    Mikuls, Ted R.
    Erickson, Alan R.
    Moore, Gerald F.
    Hearth-Holmes, Michelene
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S291 - S291
  • [3] Multifaceted roles and regulation of nucleotide-binding oligomerization domain containing proteins
    Dixon, Charneal L.
    Wu, Amy
    Fairn, Gregory D.
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [4] Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders
    Watanabe, Tomohiro
    Asano, Naoki
    Kudo, Masatoshi
    Strober, Warren
    [J]. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2017, 93 (08): : 578 - 599
  • [5] Harnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy
    Nabergoj, Sanja
    Mlinaric-Rascan, Irena
    Jakopin, Ziga
    [J]. MEDICINAL RESEARCH REVIEWS, 2019, 39 (05) : 1447 - 1484
  • [6] Nucleotide-binding oligomerization domain containing 2: Structure, function, and diseases
    Yao, Qingping
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2013, 43 (01) : 125 - 130
  • [7] Potential roles of IL-9 in the pathogenesis of systemic lupus erythematosus
    Leng, Rui-Xue
    Pan, Hai-Feng
    Ye, Dong-Qing
    Xu, Yuekang
    [J]. AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 1 (01): : 28 - 32
  • [8] Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple's disease
    Williamson, Katrina A.
    Yun, Mark
    Koster, Matthew J.
    Arment, Courtney
    Patnaik, Asha
    Chang, Tara W.
    Bledsoe, Adam C.
    Sae-Tia, Sutthichai
    Shah, Aditya S.
    Samuels, Jonathan
    Davis, John M., III
    Yao, Qingping
    [J]. RHEUMATOLOGY, 2023, : 1291 - 1296
  • [9] Expression of nucleotide-binding oligomerization domain 1 and 2 in oral lichen planus
    Ahn, Mee-Young
    Kang, Jin-Kyu
    Kwon, Seong-Min
    Yoon, Hyo-Eun
    Yoon, Jung-Hoon
    [J]. JOURNAL OF DENTAL SCIENCES, 2020, 15 (01) : 1 - 8
  • [10] A novel nucleotide-binding oligomerization domain 2 genetic marker for Yao syndrome
    Navetta-Modrov, Brianne
    Nomani, Hafsa
    Yun, Mark
    Yang, Jie
    Salvemini, Joann
    Aroniadis, Olga
    Clark, Richard
    Gorevic, Peter D.
    Yao, Qingping
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (01) : 166 - 168